PMVP

PMV Pharmaceuticals, Inc. NASDAQ Listed Sep 25, 2020

Healthcare ·Biotechnology ·US · pmvpharma.com

$1.44

Mkt Cap $76.8M

52w Low $0.81 58.9% of range 52w High $1.88

50d MA $1.44 200d MA $1.34

P/E (TTM) -0.9x

EV/EBITDA -0.3x

P/B 0.7x

Debt/Equity 0.0x

ROE -74.2%

P/FCF -0.9x

RSI (14) —

ATR (14) —

Beta 1.40

50d MA $1.44

200d MA $1.34

Avg Volume 649.6K

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.

SIC Code

2834

CIK (SEC)

1699382

Phone

609 642 6670

8 Clarke Drive · Princeton, NJ 08512 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 6, 2026	AMC	-0.40	-0.34	+15.0%	1.64	+0.6%	-0.6%	-0.6%	-1.2%	-1.2%	-1.3%	—
Nov 12, 2025	AMC	-0.40	-0.40	+0.0%	1.42	+1.4%	-4.2%	+1.5%	+2.9%	-1.4%	-2.9%	—
Aug 7, 2025	AMC	-0.39	-0.41	-5.1%	1.45	+1.4%	+2.1%	-5.4%	+1.4%	+7.0%	+2.0%	—
May 9, 2025	AMC	-0.37	-0.34	+8.1%	0.88	+1.1%	-2.1%	-1.4%	-0.8%	-0.9%	+3.3%	—
Mar 3, 2025	AMC	-0.38	-0.45	-18.4%	1.32	+0.0%	-2.3%	+6.2%	-10.2%	+0.0%	-0.8%	—
Nov 7, 2024	AMC	-0.35	-0.37	-5.7%	1.78	+2.2%	-2.2%	+0.6%	-4.6%	-1.2%	-3.0%	—
Aug 8, 2024	AMC	-0.34	-0.02	+94.1%	1.46	+0.7%	-1.4%	+3.5%	-0.7%	-2.0%	+6.2%	—
May 9, 2024	AMC	-0.35	-0.30	+14.3%	2.10	+0.5%	-2.9%	+4.4%	+0.5%	+0.9%	-0.5%	—
Feb 29, 2024	AMC	-0.39	-0.31	+20.5%	1.85	-2.7%	+1.6%	-0.5%	+0.5%	+2.7%	-3.6%	—
Nov 9, 2023	AMC	-0.45	-0.34	+24.4%	1.90	+0.0%	+5.3%	+1.5%	+9.9%	+8.1%	-4.6%	—
Aug 9, 2023	AMC	-0.47	-0.38	+19.1%	8.67	+1.4%	+1.4%	+1.6%	-8.7%	-4.5%	-6.4%	—
May 10, 2023	AMC	-0.48	-0.42	+12.5%	5.46	+0.9%	+3.3%	+1.1%	+1.4%	-2.8%	+0.5%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 20	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.28	$1.26	-1.6%	-1.6%	+0.8%	-2.4%	-2.4%	-4.1%
Aug 20	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.55	$1.58	+1.9%	+3.9%	-1.2%	-3.8%	+1.3%	+3.2%
May 30	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.80	$1.83	+1.7%	-0.6%	+1.7%	-4.9%	-1.2%	+1.2%
May 14	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.13	$2.14	+0.5%	+0.5%	+0.9%	-0.5%	-2.3%	+5.2%
Mar 7	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.93	$1.95	+1.0%	-3.6%	-8.6%	-4.1%	+1.2%	-3.0%
Oct 16	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.00	$2.06	+3.0%	-11.0%	+10.4%	+7.6%	-16.8%	-15.3%
Aug 11	HC Wainwright & Co.	Maintains	Buy → Buy	—	$8.79	$8.78	-0.1%	+1.6%	-8.7%	-4.5%	-6.4%	-1.4%
May 17	HC Wainwright & Co.	Maintains	Buy → Buy	—	$5.62	$5.72	+1.8%	+0.5%	+0.2%	-0.2%	+1.4%	-1.0%
May 11	Oppenheimer	Maintains	Outperform → Outperform	—	$5.46	$5.51	+0.9%	+3.3%	+1.1%	+1.4%	-2.8%	+0.5%
Mar 20	HC Wainwright & Co.	Maintains	Buy → Buy	—	$5.45	$5.51	+1.1%	+0.7%	-1.3%	-8.7%	+2.2%	-0.6%
Mar 2	Oppenheimer	Maintains	Outperform → Outperform	—	$6.19	$6.14	-0.8%	-4.6%	-0.1%	-1.7%	+3.6%	-2.5%
Nov 17	HC Wainwright & Co.	Maintains	Buy → Buy	—	$10.29	$10.41	+1.2%	-2.1%	-2.8%	-0.3%	+5.0%	-1.8%
Jun 9	Oppenheimer	Maintains	Outperform → Outperform	—	$10.24	$10.27	+0.3%	+1.2%	-6.9%	-4.3%	+2.3%	+4.4%
May 24	Goldman Sachs	Maintains	Buy → Buy	—	$15.00	$14.67	-2.2%	-6.1%	-7.1%	+0.9%	+16.0%	-23.3%
Mar 2	Oppenheimer	Upgrade	Perform → Outperform	—	$16.65	$17.81	+7.0%	+4.9%	-6.2%	-2.1%	+5.9%	+2.8%
Sep 22	Goldman Sachs	Upgrade	Neutral → Buy	—	$27.44	$30.00	+9.3%	+3.5%	+4.3%	-1.2%	+0.8%	+0.9%
Aug 19	Oppenheimer	Maintains	Perform → Perform	—	$32.45	$31.11	-4.1%	-12.1%	-0.2%	+8.1%	+2.1%	-2.0%
Aug 2	Guggenheim	Maintains	Buy → Buy	—	$34.01	$34.69	+2.0%	+1.1%	-0.8%	+6.8%	+0.1%	+0.4%
Jul 29	HC Wainwright & Co.	Maintains	Buy → Buy	—	$35.66	$36.03	+1.0%	-2.3%	-2.4%	+1.1%	-0.8%	+6.8%

Data updated apr 26, 2026 8:12pm · Source: massive.com